£137.71

Springer Biochemistry of Arachidonic Acid Metabolism: 1 (Prostaglandins, Leukotrienes, and Cancer, 1)

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 45 days • 45 data points (No recent data available)

Historical
Generating forecast...
£137.71 £130.82 £133.58 £136.33 £139.09 £141.84 £144.60 25 January 2026 05 February 2026 16 February 2026 27 February 2026 10 March 2026

Price Distribution

Price distribution over 45 days • 1 price levels

Days at Price
45 days 0 11 23 34 45 £138 Days at Price

Price Analysis

Most common price: £138 (45 days, 100.0%)

Price range: £138 - £138

Price levels: 1 different prices over 45 days

Description

Prostaglandins, Leukotrienes, and Cancer is a multi-volume series that will focus on an emerging area of cancer research. In 1968, R.H. Williams first reported that elevated prostaglandin levels are present in human medullary car cinoma. Since that time, the concept that arachidonic acid metabolites may be in volved in cancer has expanded to include every aspect of the disease from cell transformation through metastasis. Prostaglandins and leukotrienes are generic terms used to describe a family of bioactive lipids produced from unsaturated fatty acids (principally from arachidonic acid) via the cyclooxygenase and lipoxygenase pathways, respec tively. Cyclooxygenase products consist of diverse products such as prosta glandin E, (POE,), prostacyclin (POI2) and thromboxane A2 (TXA2), whereas lipoxygenase products consist of hydroperoxy fatty acids and mono-, di- and tri-hydroxy acids including leukotrienes. The precursor fatty acids for the cyclooxygenase and lip oxygenase pathways are present in cellular phospholipids. This finding established an important control point in their biosynthesis-the release of substrate. This occurs in response to numerous stimuli that act at the cell surface. Dr. Bengt Samuelsson's extensive study of the metabolism of pros taglandins indicated that they are rapidly inactivated on a single pass through pulmonary circulation. Thus, they cannot act as circulating hormones and appear to be made on demand in or in the vicinity of target tissues leading to the concept that prostaglandins are local hormones or autocoids.

Product Specifications

Format
Paperback
Domain
Amazon UK
Publication Date
01 October 2011
Listed Since
21 December 2012

Barcode

No barcode data available

Similar Products You Might Like

Arachidonic Acid Metabolism and Tumor Promotion: 3 (Prostaglandins, Leukotrienes, and Cancer, 3)
99% match

Arachidonic Acid Metabolism and Tumor Promotion: 3 (Prostaglandins, Leukotrienes, and Cancer, 3)

Springer

£103.70 28 Feb 2026
Springer Prostaglandins and Immunity - Cancer Research Book
98% match

Springer Prostaglandins and Immunity - Cancer Research Book

Springer

£103.70 01 Mar 2026
Carcinogenesis and Dietary Fat: 6 (Prostaglandins, Leukotrienes, and Cancer, 6)
98% match

Carcinogenesis and Dietary Fat: 6 (Prostaglandins, Leukotrienes, and Cancer, 6)

Springer

£213.13 26 Jan 2026
Springer Eicosanoids and Bioactive Lipids in Cancer Oncology
94% match

Springer Eicosanoids and Bioactive Lipids in Cancer Oncology

Springer

£206.52 05 Mar 2026
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury: Proceedings of the 2nd International Conference September 17–21, ... FRG: 71 (Developments in Oncology, 71)
93% match

Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury: Proceedings of the 2nd International Conference September 17–21, ... FRG: 71 (Developments in Oncology, 71)

Springer

£249.54 25 Jan 2026
Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3: 407 (Advances in Experimental Medicine and Biology, 407)
93% match

Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3: 407 (Advances in Experimental Medicine and Biology, 407)

Springer

£207.27 09 Dec 2025
Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3: 407 (Advances in Experimental Medicine and Biology, 407)
93% match

Eicosanoids and other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 3: 407 (Advances in Experimental Medicine and Biology, 407)

Springer

£105.91 12 Jan 2026
Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy
93% match

Prostaglandin Inhibitors in Tumor Immunology and Immunotherapy

CRC Press

£375.54 18 Apr 2026
Cancer and Inflammation Mechanisms: Chemical, Biological, and Clinical Aspects
93% match

Cancer and Inflammation Mechanisms: Chemical, Biological, and Clinical Aspects

Wiley

£103.00 20 Apr 2026
Comparative Pathophysiology and Toxicology of Cyclooxygenases
93% match

Comparative Pathophysiology and Toxicology of Cyclooxygenases

Wiley

£105.00 26 Feb 2026
Lipid Mediators and Their Metabolism in the Brain
92% match

Lipid Mediators and Their Metabolism in the Brain

Springer

£146.40 28 Jan 2026
Academic Press - Prostate Cancer Metabolism Book
92% match

Academic Press - Prostate Cancer Metabolism Book

Academic Press

£110.68 31 Mar 2026
Proteases in Human Diseases
92% match

Proteases in Human Diseases

Springer

£136.50 08 Mar 2026
Frontiers in Bioactive Lipids (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)
92% match

Frontiers in Bioactive Lipids (Gwumc Department of Biochemistry and Molecular Biology Annual Spring Symposia)

Springer

£122.44 10 Mar 2026
New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules
92% match

New Targets in Inflammation: Inhibitors of COX-2 or Adhesion Molecules

Springer

£77.75 23 Feb 2026
CRC Handbook of Eicosanoids, Volume II: Prostaglandins and Related Lipids (CRC Press Revivals)
92% match

CRC Handbook of Eicosanoids, Volume II: Prostaglandins and Related Lipids (CRC Press Revivals)

CRC Press

£226.38 10 Dec 2025
Novel Chemotherapeutic Agents: Preactivation in the Treatment of Cancer and AIDS (Medical Intelligence Unit)
92% match

Novel Chemotherapeutic Agents: Preactivation in the Treatment of Cancer and AIDS (Medical Intelligence Unit)

Springer

£77.14 26 Feb 2026
Paraoxonases in Inflammation, Infection, and Toxicology: 660 (Advances in Experimental Medicine and Biology, 660)
92% match

Paraoxonases in Inflammation, Infection, and Toxicology: 660 (Advances in Experimental Medicine and Biology, 660)

Humana

£143.17 11 Feb 2026
Perspectives in Cancer Prevention-Translational Cancer Research
92% match

Perspectives in Cancer Prevention-Translational Cancer Research

Springer

£109.68 05 Feb 2026
Druggable Lipid Signaling Pathways: 1274 (Advances in Experimental Medicine and Biology, 1274)
92% match

Druggable Lipid Signaling Pathways: 1274 (Advances in Experimental Medicine and Biology, 1274)

£106.07 15 Dec 2025
Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression: 1210 (Advances in Experimental Medicine and Biology, 1210)
92% match

Prostate Cancer: Cellular and Genetic Mechanisms of Disease Development and Progression: 1210 (Advances in Experimental Medicine and Biology, 1210)

Springer

£163.67 20 Apr 2026
Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology
92% match

Xenobiotics in Chemical Carcinogenesis: Translational Aspects in Toxicology

Academic Press

£115.29 27 Feb 2026
Humana COX-2 Blockade in Cancer Prevention and Therapy Book
92% match

Humana COX-2 Blockade in Cancer Prevention and Therapy Book

Humana

£74.81 20 Apr 2026
Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)
92% match

Mechanisms of Oncogenesis: An update on Tumorigenesis: 12 (Cancer Growth and Progression, 12)

Springer

£93.06 10 Mar 2026